CA2179086A1 - Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments - Google Patents

Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments

Info

Publication number
CA2179086A1
CA2179086A1 CA002179086A CA2179086A CA2179086A1 CA 2179086 A1 CA2179086 A1 CA 2179086A1 CA 002179086 A CA002179086 A CA 002179086A CA 2179086 A CA2179086 A CA 2179086A CA 2179086 A1 CA2179086 A1 CA 2179086A1
Authority
CA
Canada
Prior art keywords
phenyl
alkyl
alkylamino
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002179086A
Other languages
English (en)
Inventor
Adnan M. Mjalli
Sepehr Sarshar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontogen Corp
Original Assignee
Ontogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ontogen Corp filed Critical Ontogen Corp
Priority to CA002179086A priority Critical patent/CA2179086A1/fr
Publication of CA2179086A1 publication Critical patent/CA2179086A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002179086A 1996-06-13 1996-06-13 Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments Abandoned CA2179086A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002179086A CA2179086A1 (fr) 1996-06-13 1996-06-13 Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002179086A CA2179086A1 (fr) 1996-06-13 1996-06-13 Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments

Publications (1)

Publication Number Publication Date
CA2179086A1 true CA2179086A1 (fr) 1997-12-14

Family

ID=4158406

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002179086A Abandoned CA2179086A1 (fr) 1996-06-13 1996-06-13 Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments

Country Status (1)

Country Link
CA (1) CA2179086A1 (fr)

Similar Documents

Publication Publication Date Title
US5700826A (en) 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
EP0999835B1 (fr) Derives d'imidazole utilises comme modulateurs de la mdr
US7825261B2 (en) Indazole compounds
JP4691033B2 (ja) ジャイレース阻害剤およびその用途
US5710129A (en) Inhibitors of SH2-mediated processes
EP2694515B1 (fr) Inhibiteurs de protéine kinase
US20120322814A1 (en) Methods of inhibiting ire1
JP2004532234A (ja) トリアゾール由来キナーゼインヒビターおよびその使用
EP2919779B1 (fr) Composés pour la médiation d'un récepteur des cannabinoïdes
US20080207589A1 (en) Cyclized derivatives as eg-5 inhibitors
US7902359B2 (en) Decahydronaphthalene compounds
EP0812829A1 (fr) Imidazoles substitués comme modulateurs pour suppression de la résistance à plusieurs médicaments
JP2022518258A (ja) Ｎ－複素環式５員環含有カプシドタンパク質のアセンブリの阻害剤、その医薬組成物および使用
US5756527A (en) Imidazole derivatives useful as modulators of multi drug resistances
US7288545B2 (en) Piperazinedione compounds
ZA200407709B (en) Novel chalcone derivatives and uses thereof.
CN104603133A (zh) 用于治疗癌症和免疫抑制的组合疗法
CA2179086A1 (fr) Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments
US20050009054A1 (en) Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA
AU737515B2 (en) Substituted imidazoles as modulators of multi-drug resistance
CA2207753A1 (fr) Modifieurs de la resistance a plusieurs medicaments
JPH107660A (ja) 多剤耐性の調節剤である置換イミダゾール類
WO1999000364A1 (fr) Composes polycarboxamido a ramifications multiples
EP0812830A1 (fr) Modulateurs de la résistance à de multiples médicaments
AU749814B2 (en) Modulators of multi-drug resistances

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead